Related Experiment Video
Updated: Oct 15, 2025

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
[Insulin autoimmune syndrome : A rare, but important differential diagnosis of hypoglycemia]
Tiago de Castro1, Christoph Beier1, Christoph Terkamp1
1Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.
Insights
A 69-year-old woman developed recurrent hypoglycemia after taking clopidogrel. Doctors diagnosed insulin autoimmune syndrome, likely drug-induced, and treated her successfully with immunoadsorption.
Area of Science:
- Endocrinology
- Immunology
- Pharmacology
Background:
- Recurrent severe hypoglycemia can be a diagnostic challenge, necessitating the exclusion of common causes like insulinoma.
- Peripheral arterial obstructive disease (PAOD) management sometimes involves antiplatelet agents like clopidogrel.
Observation:
- A 69-year-old female presented with recurrent severe hypoglycemia.
- Despite normal to low blood glucose, serum insulin and insulin autoantibodies were elevated.
- Other causes, including insulinoma and paraneoplastic syndrome, were ruled out.
Findings:
- Insulin autoimmune syndrome (IAS) was diagnosed, strongly suspected to be induced by clopidogrel.
- Treatment with immunoadsorption led to a significant decrease in hypoglycemic episodes.
Implications:
- This case highlights clopidogrel as a potential trigger for drug-induced insulin autoimmune syndrome.
- Immunoadsorption offers an effective therapeutic option for managing this rare condition.
- Increased awareness of IAS is crucial for clinicians managing patients on specific medications.
Abstract:
A 69-year-old female patient was referred to the Medical University of Hanover for further diagnostic evaluation of recurrent severe hypoglycemia. The patient had previously been started on clopidogrel after arterial stenting for peripheral arterial obstructive disease (PAOD). The presence of an insulinoma and paraneoplastic syndrome was excluded. Increased serum insulin and insulin autoantibodies levels were confirmed, despite normal to low blood sugar levels. An insulin autoimmune syndrome was diagnosed, most likely induced by the prior intake of clopidogrel. Treatment with immunoadsorption was initiated, achieving a significant reduction in hypoglycemic events and a lasting response to treatment over 3 months.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

